Encompass Health Corp (AMEX:EHC) – Equities research analysts at William Blair raised their FY2018 earnings per share (EPS) estimates for Encompass Health in a research note issued to investors on Tuesday. William Blair analyst M. Larew now anticipates that the company will post earnings of $3.40 per share for the year, up from their prior forecast of $3.00. William Blair has a “Outperform” rating on the stock.
Encompass Health (AMEX:EHC) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The company had revenue of $995.60 million during the quarter, compared to the consensus estimate of $985.75 million. During the same quarter in the previous year, the firm earned $0.65 earnings per share. The firm’s quarterly revenue was up 7.4% on a year-over-year basis.
Encompass Health (AMEX EHC) traded down $0.34 during mid-day trading on Thursday, reaching $51.91. 268,749 shares of the company’s stock were exchanged, compared to its average volume of 695,595. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health has a 12 month low of $38.24 and a 12 month high of $52.67. The firm has a market capitalization of $5,100.00, a PE ratio of 18.95, a P/E/G ratio of 1.70 and a beta of 0.54.
A hedge fund recently bought a new stake in Encompass Health stock. Dalton Greiner Hartman Maher & Co. acquired a new stake in Encompass Health Corp (AMEX:EHC) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 331,823 shares of the company’s stock, valued at approximately $16,395,000. Dalton Greiner Hartman Maher & Co. owned 0.34% of Encompass Health as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 93.18% of the company’s stock.
In other Encompass Health news, Director Yvonne M. Curl bought 1,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were acquired at an average cost of $45.95 per share, with a total value of $45,950.00. Following the acquisition, the director now directly owns 64,144 shares of the company’s stock, valued at approximately $2,947,416.80. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 1.60% of the company’s stock.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd were issued a $0.25 dividend. The ex-dividend date of this dividend was Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.93%. Encompass Health’s payout ratio is 36.50%.
ILLEGAL ACTIVITY WARNING: This story was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.com-unik.info/2018/01/18/encompass-health-corp-forecasted-to-earn-fy2018-earnings-of-3-40-per-share-ehc.html.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.